L. Harrison

Dose Escalation of Docetaxel Concomitant With Hypofractionated, Once Weekly Chest Radiotherapy for Non-Small-Cell Lung Cancer: A Phase I Study

P. Schwarzenberger, R. Wynn, C. Theodossiou, 2004, American journal of clinical oncology.

Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Well-Differentiated Neuroendocrine Tumors of the Thorax ( Includes Lung and Thymus )

Manal M. Hassan, E. Krenning, M. Hassan, 2010 .

Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma.

A. Marrogi, J. Kolls, P. Schwarzenberger, 2000, The Annals of thoracic surgery.

Development of a human cardiac tissue-based angiogenesis model.

T. Ferguson, E. Woltering, James M. Lewis, 2006, The Journal of surgical research.

The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study.

R. Ramesh, A. Marrogi, S. Freeman, 1998, Human gene therapy.

Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study

A. Marrogi, J. Kolls, P. Schwarzenberger, 2011, Cancer Gene Therapy.

Clinical Protocol The Treatment of Malignant Mesothelioma with a Gene Modified Cancer Cell Line: A Phase I Study

R. Ramesh, A. Marrogi, S. Freeman, 1998 .

Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs

E. Woltering, J. O'leary, James M. Lewis, 2003, Annals of surgery.

Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.

P. Ye, R. Ramesh, A. Marrogi, 1998, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.